Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-24-002359
Filing Date
2024-03-04
Accepted
2024-03-04 17:18:50
Documents
59
Period of Report
2024-05-03

Document Format Files

Seq Description Document Type Size
1 PRE 14A abbv-20240503xpre14a.htm   iXBRL PRE 14A 3128450
2 GRAPHIC abbv-20240503xpre14a_a001.jpg GRAPHIC 9212
3 GRAPHIC abbv-20240503xpre14a_a002.jpg GRAPHIC 2919
4 GRAPHIC abbv-20240503xpre14a_a003.jpg GRAPHIC 3072
5 GRAPHIC abbv-20240503xpre14a_a004.jpg GRAPHIC 1946
6 GRAPHIC abbv-20240503xpre14a_a005.jpg GRAPHIC 3593
7 GRAPHIC abbv-20240503xpre14a_a006.jpg GRAPHIC 3949
8 GRAPHIC abbv-20240503xpre14a_a007.jpg GRAPHIC 4403
9 GRAPHIC abbv-20240503xpre14a_a008.jpg GRAPHIC 2964
10 GRAPHIC abbv-20240503xpre14a_a009.jpg GRAPHIC 7934
11 GRAPHIC abbv-20240503xpre14a_a012.jpg GRAPHIC 2168
12 GRAPHIC abbv-20240503xpre14a_a013.jpg GRAPHIC 1715
13 GRAPHIC abbv-20240503xpre14a_a014.jpg GRAPHIC 1735
14 GRAPHIC abbv-20240503xpre14a_a016.jpg GRAPHIC 1011
15 GRAPHIC abbv-20240503xpre14a_a019.jpg GRAPHIC 2184
16 GRAPHIC abbv-20240503xpre14a_a020.jpg GRAPHIC 4775
17 GRAPHIC abbv-20240503xpre14a_a021.jpg GRAPHIC 4910
18 GRAPHIC abbv-20240503xpre14a_a022.jpg GRAPHIC 5132
19 GRAPHIC abbv-20240503xpre14a_a023.jpg GRAPHIC 11553
20 GRAPHIC abbv-20240503xpre14a_a026.jpg GRAPHIC 6558
21 GRAPHIC abbv-20240503xpre14a_a027.jpg GRAPHIC 4955
22 GRAPHIC abbv-20240503xpre14a_a028.jpg GRAPHIC 7289
23 GRAPHIC abbv-20240503xpre14a_a029.jpg GRAPHIC 4645
24 GRAPHIC abbv-20240503xpre14a_a030.jpg GRAPHIC 6395
25 GRAPHIC abbv-20240503xpre14a_a031.jpg GRAPHIC 6705
26 GRAPHIC abbv-20240503xpre14a_a032.jpg GRAPHIC 7031
27 GRAPHIC abbv-20240503xpre14a_a033.jpg GRAPHIC 8150
28 GRAPHIC abbv-20240503xpre14a_a034.jpg GRAPHIC 7168
29 GRAPHIC abbv-20240503xpre14a_a035.jpg GRAPHIC 7387
30 GRAPHIC abbv-20240503xpre14a_a036.jpg GRAPHIC 6536
31 GRAPHIC abbv-20240503xpre14a_a037.jpg GRAPHIC 4455
32 GRAPHIC abbv-20240503xpre14a_a038.jpg GRAPHIC 6108
33 GRAPHIC abbv-20240503xpre14a_a050.jpg GRAPHIC 52642
34 GRAPHIC abbv-20240503xpre14a_a051.jpg GRAPHIC 58773
35 GRAPHIC abbv-20240503xpre14a_a054.jpg GRAPHIC 28645
36 GRAPHIC abbv-20240503xpre14a_a055.jpg GRAPHIC 30744
37 GRAPHIC abbv-20240503xpre14a_a063.jpg GRAPHIC 44302
38 GRAPHIC abbv-20240503xpre14a_a064.jpg GRAPHIC 41153
39 GRAPHIC abbv-20240503xpre14a_a071.jpg GRAPHIC 4444
40 GRAPHIC abbv-20240503xpre14a_bg001.jpg GRAPHIC 147058
41 GRAPHIC abbv-20240503xpre14a_bg002.jpg GRAPHIC 101416
42 GRAPHIC abbv-20240503xpre14a_bg003.jpg GRAPHIC 146808
43 GRAPHIC abbv-20240503xpre14a_bg004.jpg GRAPHIC 114272
  Complete submission text file 0001558370-24-002359.txt   7037839

Data Files

Seq Description Document Type Size
44 EX-101.SCH abbv-20240503.xsd EX-101.SCH 8146
45 EX-101.DEF abbv-20240503_def.xml EX-101.DEF 10228
46 EX-101.LAB abbv-20240503_lab.xml EX-101.LAB 16409
47 EX-101.PRE abbv-20240503_pre.xml EX-101.PRE 9670
60 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20240503xpre14a_htm.xml XML 456773
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35565 | Film No.: 24715658
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)